ROYAL BANK OF CANADA - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 75 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 27.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$62,000
+14.8%
76,924
-0.1%
0.00%
Q1 2023$54,000
-1.8%
76,996
-0.3%
0.00%
Q4 2022$55,000
-85.6%
77,246
-69.2%
0.00%
Q3 2022$381,000
+74.0%
250,538
+13.7%
0.00%
Q2 2022$219,000
-32.4%
220,258
-2.2%
0.00%
Q1 2022$324,000
-73.7%
225,174
-4.8%
0.00%
Q4 2021$1,234,000
-3.2%
236,421
+8.0%
0.00%
Q3 2021$1,275,000
-25.2%
218,892
+3.4%
0.00%
Q2 2021$1,705,000
+5.4%
211,642
+8.9%
0.00%
Q1 2021$1,617,000
+15.2%
194,270
+4.9%
0.00%
Q4 2020$1,404,000
-44.6%
185,142
-22.2%
0.00%
-100.0%
Q3 2020$2,536,000
-17.0%
237,848
+18.1%
0.00%0.0%
Q2 2020$3,054,000
+351.1%
201,465
+147.9%
0.00%
Q1 2020$677,000
-62.1%
81,272
-23.0%
0.00%
-100.0%
Q4 2019$1,784,000
+23.9%
105,544
+36.1%
0.00%0.0%
Q3 2019$1,440,000
+10976.9%
77,557
+12656.1%
0.00%
Q2 2019$13,0000.0%608
-1.3%
0.00%
Q1 2019$13,000
+85.7%
616
-2.4%
0.00%
Q4 2018$7,000
-91.6%
631
-82.5%
0.00%
Q3 2018$83,000
+23.9%
3,610
+17.9%
0.00%
Q2 2018$67,000
-6.9%
3,063
-2.9%
0.00%
Q1 2018$72,000
-12.2%
3,155
-0.4%
0.00%
Q4 2017$82,000
-30.5%
3,168
-40.4%
0.00%
Q3 2017$118,000
+29.7%
5,311
+61.1%
0.00%
Q2 2017$91,000
-6.2%
3,296
-18.2%
0.00%
Q1 2017$97,000
+273.1%
4,031
+216.4%
0.00%
Q4 2016$26,000
-72.6%
1,274
-63.4%
0.00%
Q3 2016$95,000
+90.0%
3,4800.0%0.00%
Q2 2016$50,000
-80.1%
3,480
-80.1%
0.00%
Q1 2016$251,000
-25.1%
17,485
+12.0%
0.00%
Q4 2015$335,000
+679.1%
15,615
+479.6%
0.00%
Q3 2015$43,000
-41.9%
2,694
-5.8%
0.00%
Q2 2015$74,000
+7.2%
2,860
-7.3%
0.00%
Q1 2015$69,000
-28.1%
3,086
-38.4%
0.00%
Q4 2014$96,000
-9.4%
5,013
+2.0%
0.00%
Q3 2014$106,000
+1414.3%
4,915
+858.1%
0.00%
Q3 2013$7,0005130.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders